<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175751/" ref="ordinalpos=163&amp;ncbi_uid=3227758&amp;link_uid=PMC3175751" image-link="/pmc/articles/PMC3175751/figure/F2/" class="imagepopup">Fig. 2.  From: Emerging Roles of Nodal and Cripto-1: From Embryogenesis to Breast Cancer Progression. </a></div><br /><div class="p4l_captionBody">Schematic Overview of Nodal and Cripto-1 Signaling Pathways. <b>A</b>) Canonical Nodal signaling using Cripto-1 as a co-receptor. Nodal can also activate this pathway, albeit less efficiently, independently of Cripto-1. <b>B</b>) Cripto-1 Nodal-independent signaling via binding with Glypican-1 and activating src/Ras/raf/PI3K downstream signaling. <b>C</b>) Possible signaling of Cripto-1 through binding to beta-integrins and signaling via FAK-dependent signaling pathway.</div></div>